Abstract Details

Title The Effects of Dalfampridine on Walking Speed, Endurance, and Community Participation in a Veteran Population: A Retrospective Cohort Study

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 123

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Shannon N. Overs, MD	No disclosure on file
Mary Fitzpatrick, ANP, MPH (Oregon Health & Science University)	No disclosure on file
	No disclosure on file
Ruth H. Whitham, MD, FAAN	No disclosure on file
Michelle Cameron, MD (Oregon Health and Science University)	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Enchi Liu, PhD (JANSSEN Alzheimer Immunotherapy)	No disclosure on file
	No disclosure on file

��ɫ��